[18F]dabrafenib
[18F]达拉非尼
Report date: 2022/05/24 15:24:37
Base Information
Drug Name[18F]dabrafenib
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Clinical)
Highest Status in ChinaN/A
Originator CompaniesUmcg The University Medical Center Groningen
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesUmcg The University Medical Center Groningen
Active IndicationsN/A
Inactive Indications